Cell Reserves Inc
Next-generation molecular shield therapeutics
- Headquarters
- Ontario
- Employees
- 1–10
- Founded
- 2016
- Business Model
- B2B
- Website
- cellreserves.com
- Total Funding
- $250K
About
Cell Reserves is a Canadian biopharmaceutical company developing next-generation protein and peptide-based therapeutics using molecular shield technology to improve persistence and bio-availability of drugs in circulation. The company focuses on treatments for autoimmune diseases, with delivery research targeting nasal, oral, and epithelial cell pathways to reduce disease management costs.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account